https://orcid.org/0000-0003-2341-8648
References
- Nikolic B, Jankovic S, Stojanov O, Popovic J. Prevalence and predictors of potential drug-drug interactions. Cent Eur J Med. 2014. doi:10.2478/s11536-013-0272-4
- McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006;119(8):624–638. doi:10.1016/j.amjmed.2005.10.039
- Sabater A, Ciudad CJ, Cendros M, Dobrokhotov D, Sabater-Tobella J. G-nomic: a new pharmacogenetics interpretation software. Pharmgenomics Pers Med. 2019. doi:10.2147/PGPM.S203585
- Tsai HH, Lin HW, Lu YH, Chen YL, Mahady GB. A review of potential harmful interactions between anticoagulant/antiplatelet agents and chinese herbal medicines. PLoS One. 2013. doi:10.1371/journal.pone.0064255
- Srinivas NR. Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives. J Pharm Pharm Sci. 2013;16(2):289. doi:10.18433/j3ng6z
- Hidaka M, Nagata M, Kawano Y, et al. Inhibitory effects of fruit juices on cytochrome P450 2C9 activity in vitro. Biosci Biotechnol Biochem. 2008;72(2):406–411. doi:10.1271/bbb.70511
- Agundez J, Martinez C, Perez-Sala D, et al. Pharmacogenomics in Aspirin Intolerance. Curr Drug Metab. 2009;10(9):998–1008. doi:10.2174/138920009790711814
- Cohen MG, Rossi JS, Garbarino J, et al. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thromb Res. 2011;128(4):335–340. doi:10.1016/j.thromres.2011.04.023
- Stockley’s herbal medicines interactions: a guide to the interactions of herbel medicines, dietary supplements and nutraceuticals with conventional medicines. Choice Rev. 2010. Availble form: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204353s020lbl.pdf. Accessed August 2, 2021. doi:10.5860/choice.47-2357